• Conmed Corp CNMD.N reported quarterly adjusted earnings of $1.15​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 98 cents. The mean expectation of six analysts for the quarter was for earnings of $1.12 per share. Wall Street expected results to range from $1.10 to $1.14 per share.

• Revenue rose 3.1% to $342.35 million from a year ago; analysts expected $338.17 million.

• Conmed Corp's reported EPS for the quarter was 69 cents​.

• The company reported quarterly net income of $21.42 million.

• Conmed Corp shares had fallen by 3.4% this quarter and lost 26.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for Conmed Corp is $69.00, about 27.3% above its last closing price of $50.14

This summary was machine generated from LSEG data July 30 at 09:55 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)